investigated the relationship between the expression of these tight junction proteins and
clinicopathologic parameters. Claudin-1 and 4 expressions were determined by
immunohistochemical methods, and the rate of cells expressing these tight junction proteins
were calculated with stereologic methods. Fifty-nine colon cancer cases were enrolled in the
study group. Claudin-1 and 4 expressions were found to be significantly lower in cases with …